Variantyx

Framingham, MA · Founded 2014 · Privately Held (backing)

Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology. Variantyx is based in Framingham, MA and was founded in 2014. It was valued at $98 million at its later-stage round in Apr 2024, the last priced event on record. It has raised $175 million across 1 recorded round; the latest was a $15.6 million early-stage round in Feb 2021.

PMV mark · valuation
$98.0M
Oct 2026
Priced at
its later-stage round
Apr 2024
Total raised
$175.3M
Last round
Early Stage VC
Feb 2021

Who backs Variantyx?

11 investors
InvestorType
OrbiMedGrowth equity
Pitango Venture CapitalVenture capital
Bosch VenturesFund of funds
Peregrine VenturesVenture capital
New Era Capital PartnersVenture capital
Soleus CapitalPE / buyout
20/20 HealthCare PartnersFamily office
GHS Investment Management (Canada) Company—
IBM Ventures—
Peregrine Systems—
+ 1 more investors · a free Private Market View account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Variantyx investors

11 investors are on record for Variantyx, including OrbiMed, Pitango Venture Capital, Bosch Ventures and Peregrine Ventures. By type, the record holds 3 venture capital firms, 1 family office and 1 private equity firm. The early-stage round in Feb 2021 drew 8 investors.

Private Market View
More of Variantyx with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Variantyx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Variantyx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View